$ABBV AbbVie Q3 Earnings Adj. EPS $3.82, est. $3.74 Net rev. $17.40B, est. $17.34B Skyrizi rev. $5.78B, est. $5.74B Rinvoq rev. $2.71B, est. $2.70B Humira rev. $683M, est. $679.3M Imbruvica rev. $522M, est. $527.3M Sees FY Adj EPS $13.95 to $13.99, saw $13.76 to $13
$ABBV AbbVie Q3 Earnings Adj.
EPS $3.82, est. $3.74 Net rev. $17.40B, est. $17.34B Skyrizi rev. $5.78B, est. $5.74B Rinvoq rev. $2.71B, est. $2.70B Humira rev. $683M, est. $679.3M Imbruvica rev. $522M, est. $527.3M Sees FY Adj
EPS $13.95 to $13.99, saw $13.76 to $13.96| FJ
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
